Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Oct 03 03:34PM ET
63.80
Dollar change
-0.89
Percentage change
-1.37
%
Index- P/E- EPS (ttm)-0.94 Insider Own6.44% Shs Outstand110.80M Perf Week2.38%
Market Cap7.07B Forward P/E- EPS next Y-1.51 Insider Trans-10.99% Shs Float103.66M Perf Month9.82%
Income-96.75M PEG- EPS next Q-0.24 Inst Own73.93% Short Float15.35% Perf Quarter24.45%
Sales0.00M P/S- EPS this Y-9.62% Inst Trans-0.29% Short Ratio4.56 Perf Half Y-13.40%
Book/sh8.31 P/B7.68 EPS next Y-50.89% ROA-14.36% Short Interest15.91M Perf Year492.42%
Cash/sh8.50 P/C7.50 EPS next 5Y40.00% ROE-14.80% 52W Range8.28 - 99.41 Perf YTD242.85%
Dividend Est.- P/FCF- EPS past 5Y-18.89% ROI-10.50% 52W High-35.82% Beta1.01
Dividend TTM- Quick Ratio37.69 Sales past 5Y0.00% Gross Margin- 52W Low670.58% ATR (14)3.80
Dividend Ex-Date- Current Ratio37.69 EPS Y/Y TTM-3.58% Oper. Margin0.00% RSI (14)52.52 Volatility4.76% 5.95%
Employees27 Debt/Eq0.00 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price110.75
Option/ShortYes / Yes LT Debt/Eq0.00 EPS Q/Q-3.81% Payout- Rel Volume0.47 Prev Close64.69
Sales Surprise- EPS Surprise23.84% Sales Q/Q- EarningsJul 24 AMC Avg Volume3.49M Price63.80
SMA202.38% SMA505.51% SMA20016.92% Trades Volume1,537,436 Change-1.37%
Date Action Analyst Rating Change Price Target Change
Sep-11-24Initiated JP Morgan Overweight $80
Jun-27-24Initiated Morgan Stanley Overweight $105
May-16-24Upgrade Raymond James Outperform → Strong Buy $115 → $116
Mar-26-24Reiterated Oppenheimer Outperform $116 → $138
Mar-07-24Initiated Jefferies Buy $110
Feb-28-24Reiterated Oppenheimer Outperform $46 → $116
May-31-23Resumed ROTH MKM Buy $32
Mar-28-23Reiterated Maxim Group Buy $15 → $25
Mar-17-23Initiated Stifel Buy $22
Jul-29-21Resumed BTIG Research Buy $20
Oct-02-24 05:00AM
Sep-30-24 06:34PM
Sep-29-24 08:30AM
06:17AM
Sep-28-24 07:03AM
05:45PM Loading…
Sep-27-24 05:45PM
Sep-26-24 08:22PM
Sep-25-24 06:08PM
05:50PM
Sep-23-24 07:30AM
Sep-21-24 10:39AM
Sep-20-24 06:14PM
01:17PM
Sep-16-24 05:50PM
Sep-15-24 07:21AM
02:45PM Loading…
Sep-13-24 02:45PM
06:45AM
03:51AM
Sep-12-24 07:12PM
09:30AM
04:15AM
Sep-11-24 05:08PM
04:30PM
04:29PM
Sep-09-24 05:45PM
Sep-07-24 04:26AM
Sep-05-24 06:05AM
Sep-04-24 05:50PM
05:41AM
Sep-03-24 09:45AM
09:00AM Loading…
Aug-31-24 09:00AM
Aug-30-24 11:12AM
Aug-29-24 01:19PM
07:16AM
Aug-28-24 04:03PM
Aug-27-24 08:56PM
06:42PM
04:01PM
09:30AM
Aug-26-24 10:20AM
07:30AM
04:57AM
Aug-25-24 02:14PM
02:14PM
Aug-23-24 11:04AM
01:01AM
Aug-21-24 04:50PM
Aug-20-24 10:54AM
01:00AM
Aug-17-24 06:09AM
Aug-16-24 09:13PM
Aug-15-24 01:13AM
Aug-13-24 02:00PM
Aug-11-24 08:09AM
Aug-08-24 08:29PM
Aug-04-24 09:03AM
Aug-03-24 07:45AM
Aug-02-24 08:15AM
07:30AM
Aug-01-24 03:20PM
07:00AM
Jul-30-24 07:35AM
Jul-29-24 03:31PM
02:53PM
08:45AM
07:30AM
04:20AM
Jul-27-24 05:20AM
Jul-26-24 04:07PM
01:55PM
11:03AM
10:38AM
07:37AM
Jul-25-24 07:06PM
04:11PM
01:14PM
12:13PM
12:03PM
12:01PM
12:01PM
11:24AM
11:03AM
09:44AM
09:29AM
06:28AM
05:00AM
Jul-24-24 04:05PM
Jul-22-24 09:20AM
Jul-21-24 06:59AM
Jul-20-24 06:00AM
Jul-19-24 05:45PM
09:51AM
05:50AM
Jul-18-24 05:50PM
07:00AM
Jul-17-24 04:12PM
04:05PM
10:47AM
08:45AM
07:25AM
Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SINGLETON J MATTHEWDirectorSep 20 '24Option Exercise1.1910,30012,25719,800Sep 20 09:21 PM
SINGLETON J MATTHEWDirectorSep 20 '24Sale69.5010,300715,8509,500Sep 20 09:21 PM
Lian BrianPresident & CEOSep 20 '24Option Exercise7.77166,1301,290,8302,521,057Sep 20 09:20 PM
Lian BrianPresident & CEOSep 20 '24Sale70.83216,13015,308,5532,304,927Sep 20 09:20 PM
Lian BrianOfficerSep 20 '24Proposed Sale18.41216,1303,978,372Sep 20 04:29 PM
SINGLETON J MATTHEWDirectorSep 20 '24Proposed Sale69.5010,300715,850Sep 20 04:13 PM
Lian BrianPresident & CEOAug 21 '24Option Exercise7.771,0007,7702,355,927Aug 22 07:23 PM
Lian BrianPresident & CEOAug 21 '24Sale69.901,00069,9002,354,927Aug 22 07:23 PM
SINGLETON J MATTHEWDirectorAug 21 '24Option Exercise1.195,7006,78315,200Aug 22 07:23 PM
SINGLETON J MATTHEWDirectorAug 21 '24Sale69.725,700397,4309,500Aug 22 07:23 PM
Lian BrianOfficerAug 21 '24Proposed Sale69.901,00069,900Aug 21 04:30 PM
SINGLETON J MATTHEWDirectorAug 21 '24Proposed Sale69.725,700397,404Aug 21 04:18 PM
Lian BrianPresident & CEOAug 19 '24Option Exercise7.77112,870877,0002,467,797Aug 19 08:13 PM
Lian BrianPresident & CEOAug 19 '24Sale65.80112,8707,426,5082,354,927Aug 19 08:13 PM
SINGLETON J MATTHEWDirectorAug 19 '24Option Exercise3.3316,00053,28025,500Aug 19 08:11 PM
SINGLETON J MATTHEWDirectorAug 19 '24Sale62.2216,000995,4539,500Aug 19 08:11 PM
Lian BrianOfficerAug 19 '24Proposed Sale65.79112,8707,425,717Aug 19 08:00 PM
SINGLETON J MATTHEWDirectorAug 19 '24Proposed Sale62.2116,000995,360Aug 19 07:47 PM
SINGLETON J MATTHEWDirectorAug 14 '24Option Exercise8.0020,786166,28830,286Aug 14 08:03 PM
SINGLETON J MATTHEWDirectorAug 14 '24Sale57.5320,7861,195,7369,500Aug 14 08:03 PM
SINGLETON J MATTHEWDirectorAug 14 '24Proposed Sale57.5320,7861,195,735Aug 14 04:38 PM
ZANTE GREGChief Financial OfficerJul 30 '24Sale57.1516,136922,212187,052Jul 31 04:05 PM
Lian BrianPresident & CEOJul 30 '24Sale57.58115,8596,670,6042,354,927Jul 31 04:05 PM
Mancini MariannaChief Operating OfficerJul 30 '24Sale57.1318,0261,029,912362,149Jul 31 04:05 PM
GREG ZANTEOfficerJul 30 '24Proposed Sale57.1516,136922,232Jul 30 05:58 PM
MARIANNA MANCINIOfficerJul 30 '24Proposed Sale57.1318,0261,029,888Jul 30 05:56 PM
BRIAN LIANOfficerJul 30 '24Proposed Sale57.58115,8596,671,057Jul 30 05:55 PM
ZANTE GREGChief Financial OfficerMay 03 '24Option Exercise4.8634,249166,285241,610May 03 08:51 PM
ZANTE GREGChief Financial OfficerMay 03 '24Sale74.6966,7564,986,008174,854May 03 08:51 PM
Mancini MariannaChief Operating OfficerMay 01 '24Option Exercise6.18281,4251,740,575629,933May 02 09:27 PM
Mancini MariannaChief Operating OfficerMay 01 '24Sale78.66281,42522,136,474348,508May 02 09:27 PM
Lian BrianPresident & CEOFeb 09 '24Sale29.9045,0001,345,5002,139,882Feb 09 08:59 PM
Lian BrianPresident & CEOFeb 08 '24Option Exercise3.76189,079711,3672,404,882Feb 08 07:40 PM
Lian BrianPresident & CEOFeb 08 '24Sale26.87269,0797,230,7842,184,882Feb 08 07:40 PM
Rouan Sarah KathrynDirectorFeb 08 '24Option Exercise8.3225,000208,00025,000Feb 08 07:38 PM
Rouan Sarah KathrynDirectorFeb 08 '24Sale28.0525,000701,2500Feb 08 07:38 PM
Lian BrianPresident & CEOJan 31 '24Option Exercise1.2385,000104,5502,349,882Jan 31 08:39 PM
Lian BrianPresident & CEOJan 31 '24Sale24.7185,0002,100,7502,264,882Jan 31 08:39 PM
Lian BrianPresident & CEOJan 30 '24Option Exercise1.2335,00043,0502,299,882Jan 30 09:05 PM
Lian BrianPresident & CEOJan 30 '24Sale23.9535,000838,2502,264,882Jan 30 09:05 PM
Rouan Sarah KathrynDirectorJan 19 '24Option Exercise8.3230,000249,60030,000Jan 19 08:35 PM
Rouan Sarah KathrynDirectorJan 19 '24Sale23.0530,000691,5000Jan 19 08:35 PM
ZANTE GREGChief Financial OfficerJan 04 '24Sale17.9015,000268,500180,730Jan 04 09:35 PM